COMPARISON OF PLAIN BLOCKS FOR POSTOPERATIVE PAIN MANAGEMENT IN GYNECOLOGICAL ABDOMINAL SURGERIES
Launched by CUKUROVA UNIVERSITY · Jun 12, 2025
Trial Information
Current as of November 14, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is comparing three different nerve-block techniques (ESP, QLB, and TAP) with no block to see which helps reduce pain after gynecologic abdominal surgery. In four groups of about 20 people each, participants will receive one of the blocks or no block before waking up, with injections given under ultrasound guidance. The main goal is to see how much morphine patients use in the first 24 hours after surgery. Researchers will also look at pain scores, overall satisfaction, need for extra pain medicine, and any side effects.
Who can participate? Women aged 18–69 who are scheduled for major gynecologic abdominal surgery and are generally in good health (ASA 1–2). People with very high surgical risk, obesity (BMI over 40), bleeding disorders or anticoagulant use, allergies to study drugs, or inability to use a patient-controlled analgesia device are not eligible. The study is currently enrolling in Adana, Turkey, and plans to include about 80 participants in total. Results are expected later in 2025.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • aged between 18 and 69 years, with ASA 1-2 score scheduled to undergo major gynecological abdominal surgery
- Exclusion Criteria:
- • ASA score 3 or above, patients younger than 18 or older than 69 years, patients with bleeding disorders or using anticoagulants, patients with a body mass index over 40, patients with known allergies to any drugs used in the study, and patients who could not or did not wish to use Patient-Controlled Analgesia (PCA) device
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, Turkey
Adana, Sarıçam, Turkey
Patients applied
Trial Officials
Hakkı Ünlügenç, Professör
Study Director
Cukurova University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported